Veterinary Blog for Education, Careers, and Real Vet Life

Welcome to the Vet Candy Blog—your go-to destination for veterinary education, career growth, and real-life insights from the world of animal health.

From free RACE-approved CE courses and clinical updates to NAVLE prep and career advice, our content is designed for veterinarians, vet techs, and students who want to stay informed, inspired, and ahead in their careers.

A young woman with curly hair smiling while looking at her phone in a bright indoor setting.

Latest Veterinary News & Clinical Insights

Felycin®-CA1 is the First and Only Drug FDA Conditionally Approved for the Management of Ventricular Hypertrophy in Cats
Jill Lopez Jill Lopez

Felycin®-CA1 is the First and Only Drug FDA Conditionally Approved for the Management of Ventricular Hypertrophy in Cats

PBI-Gordon Companies, Inc. the parent company of TriviumVet, which holds sole conditional approval from the FDA for Felycin®-CA1 (sirolimus delayed-release tablets) sold under the PRN Pharmacal brand of its affiliated company Pegasus, today announced the product is now available via licensed veterinarians nationwide. PBI-Gordon Companies, Inc. confirms that Felycin®-CA1 is the only drug currently legally marketed under conditional approval from the Food and Drug Administration (FDA) for the management HCM in cats.

Read More

Your Questions, Answered